Predictor RIO TNBC
收藏NIAID Data Ecosystem2026-03-11 收录
官方服务：
资源简介：
In this study, samples fom a window study of the PARP inhibitor rucaparib in patients with primary triple negative or BRCA1/2 related breast cancer (RIO trial) will be investigated. Samples will undergo whole genome sequence and analysis, including use of HR Predict.EGA study EGAS00001002805
创建时间：
2019-04-04
